JLE

Revue de neuropsychologie

MENU

Un nouveau test évaluant les fonctions exécutives cognitives voit le jour ! Volume 10, numéro 2, Avril-Mai-Juin 2018

  • [1] Grotz C, Seron X, Adam S. Alphaflex : un nouveau test exécutif. Rev Neuropsychol 2018 ; 10 : 168-78.
  • [2] Reitan R.M. Validity of the Trail Making test as an indicator of organic brain damage. Percept Mot Skills. 1958;8:271-276.
  • [3] Stroop J.R. Studies of interference in serial verbal reaction. J Exp Psychol. 1935;18:643-662.
  • [4] Godefroy O., Lhullier C., Rousseaux M. Non-spatial attention disorders in patients with frontal or posterior brain damage. Brain. 1996;119:191-202.
  • [5] Burgess P.W., Shallice T. Response suppression, initiation and strategy use following frontal lobe lesions. Neuropsychologia. 1996;34:263-273.
  • [6] Posner M.I., Petersen S.E. The attention system of the human brain. Annu Rev Neurosci. 1990;13:25-42.
  • [7] Godefroy O., Martinaud O., Verny M. Crossvalidation of a shortened battery for the assessment of dysexecutive disorders in Alzheimer's disease. Alzheimer Dis Assoc Disord. 2016;30:140-144. On the behalf of the GREFEX and REFLEX study groups
  • [8] Roussel M., Lhommée E., Narme P. Dysexecutive syndrome in Parkinson's disease : the GREFEX study. Aging Neuropsychol Cogn. 2016;7:1-12. On behalf of the GREFEX study group
  • [9] Roussel M., Martinaud O., Hénon H. The Behavioral and Cognitive Executive Disorders of Stroke : The GREFEX Study. PLoS One. 2016;11:e0147602. GREFEX study group
  • [10] Boone M., Roussel M., Chauffert B. Prevalence and profile of cognitive impairment in adult glioma : a sensitivity analysis. J Neurooncol. 2016;129:1123-1130.
  • [11] Azouvi P., Vallat-Azouvi C., Joseph P.A. Executive Functions Deficits After Severe Traumatic Brain Injury : The GREFEX Study. J Head Trauma Rehabil. 2015;31:E10-20. GREFEX Study Group (Groupe de réflexion sur lʼévaluation des fonctions exécutives)
  • [12] Godefroy O., Azouvi P., Robert P. Dysexecutive syndrome : diagnostic criteria and validation study. Ann Neurol. 2010;68:855-864. on the behalf of the GREFEX study group